Literature DB >> 12096946

Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction.

Nabil Dib1, Edward B Diethrich, Ann Campbell, Noreen Goodwin, Barb Robinson, James Gilbert, Dan W Hobohm, Doris A Taylor.   

Abstract

PURPOSE: To assess the technical feasibility of percutaneous endoventricular injection of skeletal myoblasts into an infarcted porcine myocardium.
METHODS: A skeletal muscle biopsy was obtained from a donor pig and processed for myoblast expansion in vitro. Myocardial infarction was induced in a host pig via fibrin coil placement in the left anterior descending artery. Four weeks later, electromechanical mapping of the left ventricle identified the infarction site, into which approximately 200 million allogenic cells obtained from the muscle biopsy were directly injected (0.1 mL/injection at 25 sites) from inside the ventricular cavity via a needle injection catheter inserted through the femoral artery. Ten days after transplantation, the injected heart was evaluated histologically for the presence of myoblasts.
RESULTS: Electrocardiography, echocardiography, left ventricular angiography, and electromechanical mapping confirmed the myocardial infarction. During the cell transfer procedure, premature ventricular contractions confirmed needle placement in the endocardium. Histological evaluation of the host heart 10 days after cell transfer revealed living myoblasts and multinucleated myotubes in the infarcted region, indicating successful transplantation.
CONCLUSIONS: Direct myoblast transplantation into infarcted porcine myocardium using an endoventricular injection was technically feasible. The results in this model show that transplanted myoblasts were able to survive for 10 days after transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 12096946     DOI: 10.1177/152660280200900310

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  10 in total

Review 1.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

Review 2.  Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System.

Authors:  Peter J Psaltis; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2008-12-10       Impact factor: 4.132

3.  Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.

Authors:  Jennifer M Singelyn; Priya Sundaramurthy; Todd D Johnson; Pamela J Schup-Magoffin; Diane P Hu; Denver M Faulk; Jean Wang; Kristine M Mayle; Kendra Bartels; Michael Salvatore; Adam M Kinsey; Anthony N Demaria; Nabil Dib; Karen L Christman
Journal:  J Am Coll Cardiol       Date:  2012-02-21       Impact factor: 24.094

Review 4.  Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.

Authors:  Jennifer M Singelyn; Karen L Christman
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

5.  Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor.

Authors:  Husnain Kh Haider; Lei Ye; Shujia Jiang; Ruowen Ge; Peter K Law; Terrance Chua; Phillip Wong; Eugene K W Sim
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

6.  Myocardial infarction and intramyocardial injection models in swine.

Authors:  Frederic C McCall; Kartik S Telukuntla; Vasileios Karantalis; Viky Y Suncion; Alan W Heldman; Muzammil Mushtaq; Adam R Williams; Joshua M Hare
Journal:  Nat Protoc       Date:  2012-07-12       Impact factor: 13.491

7.  Effects on arrhythmogenesis and arrhythmic threshold of injection of autologous fibroblasts into myocardial infarcts in adult pigs.

Authors:  Fernando Tondato; Keith Robinson; Jianhua Cui; Traci Goodchild; Nicolas Chronos; Nicholas S Peters
Journal:  J Cardiovasc Transl Res       Date:  2011-08-25       Impact factor: 4.132

Review 8.  Cell augmentation strategies for cardiac stem cell therapies.

Authors:  Raquel Cruz-Samperio; Millie Jordan; Adam Perriman
Journal:  Stem Cells Transl Med       Date:  2021-03-04       Impact factor: 6.940

Review 9.  Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease.

Authors:  Rajeswari Ravichandran; Jayarama Reddy Venugopal; Subramanian Sundarrajan; Shayanti Mukherjee; Seeram Ramakrishna
Journal:  Int J Nanomedicine       Date:  2012-12-13

Review 10.  Cell therapy for cardiovascular disease: a comparison of methods of delivery.

Authors:  Nabil Dib; Harris Khawaja; Samantha Varner; Megan McCarthy; Ann Campbell
Journal:  J Cardiovasc Transl Res       Date:  2010-12-23       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.